StockData
Bluejay Diagnostics, Inc. logo

Bluejay Diagnostics, Inc. (BJDX) income statement

BJDXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$1.83−0.32 (-15.08%)

Close on Nov 18, 2026Market cap $8.18MP/E –Yield –

Bluejay Diagnostics, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2025
-117.0%

Financial strength

Current ratio
4.64
Debt to equity
–
Debt to assets
–
Cash to current liabilities
453.5%

Valuation

P/E ratio
–
Price to sales
–
Price to book
0.87
Dividend yield
–

See a number that looks wrong?